Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biological Standardization of Lolium Perenne Allergen Extract
NCT01394289Phase 2Completed
- Sponsor
- LETI Pharma
- Start
- Sep 2011
- Primary completion
- Nov 2011
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lolium allergen extract in allergic rhinitis due to grass pollen, sponsored by LETI Pharma. Primary endpoint: Wheal size area at 30 months. Started Sep 2011; status: completed.
02
Drugs
lolium allergen extract
03
Conditions
allergic rhinitis due to grass pollen
Beyond the preview
Go deeper on NCT01394289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01394289.